NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-10-27 15:37இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Fairchem Organics Q2 FY27 Concall: Revenue Up 49.7% YoY to ₹167 Cr, PAT at ₹10.2 Cr
Fairchem Organics released the transcript for its Q2 & H1 FY27 earnings conference call. Revenue from operations for Q2 FY27 jumped 49.7% YoY to ₹167 crore, with EBITDA margin at 10.5% and net profit of ₹10.2 crore. Operating metrics improved with average realisations rising to ₹135/kg from ₹106/kg in Q2 FY26. Management noted capacity utilisation is currently around 60-65%, targeting a 5% improvement per quarter aided by lower raw material duty on crude soybean oil (reduced from 16.5% to 11%).
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the formal transcript detailing management commentary on Q2 FY27 operational turnaround, raw material tailwinds, and export ramp-up plans.
ஏன் இது முக்கியம்Confirms sustained margin and volume recovery following a sluggish FY26, driven by raw material duty cuts (16.5% to 11%) and higher product realisations.
Q2 FY27 Revenue: ரூ. 167 கோடிQ2 FY27 EBITDA margin: 10.5%Q2 FY27 Net Profit: ரூ. 10.2 கோடிCapacity utilization: 60% முதல் 65% வரைCrude Soybean Oil import duty reduction: 16.5% முதல் 11% வரை
📅 குறுகிய காலம்Operating momentum appears strong into H2 FY27 as lower raw material costs improve gross spreads and order execution.
📈 நீண்ட காலம்Long-term re-rating relies on scaling Isostearic Acid exports to cosmetic end-markets and unlocking operating leverage from higher capacity utilisation.
⚠ அபாய எச்சரிக்கைகள்
Global export headwinds and extended regulatory/approval cycles in Europe and USA
Fluctuations in vegetable oil import duties impacting raw material sourcing
👀 கவனிக்க வேண்டியவை
Track capacity utilisation progression toward the targeted 85-90% range and monitor the commercial export scale-up of Isostearic Acid in European and US markets.
Fairchem Organics Reports H1 FY27 Revenue of ₹343.1 Cr and PAT of ₹20.2 Cr in Investor Update
Fairchem Organics released its Q2/H1 FY27 investor presentation, reporting H1 FY27 revenue of ₹343.1 Cr, EBITDA of ₹35.4 Cr, and PAT of ₹20.2 Cr, indicating a strong rebound compared to full-year FY26 PAT of ₹6.2 Cr. The company's annualized return ratios improved significantly in H1 FY27, with ROCE reaching 19.62% (up from 3.88% in FY26) and ROE rising to 14.71% (up from 2.09% in FY26). Net debt-to-equity moderated to 0.24x, while the cash conversion cycle shortened to 82 days compared to 128 days in FY26. Management is targeting to scale exports up to 25% initially and eventually 50% of sales, supported by favorable US tariffs and proposed FTA talks with EU/UK.
உச்சம் நம்பிக்கை
என்ன மாறியதுFairchem Organics issued its Q2/H1 FY27 investor presentation highlighting operational turnaround and outlining export expansion targets.
ஏன் இது முக்கியம்The company's earnings and capital return metrics showed a marked recovery in H1 FY27 following compressed margins and sluggish demand during FY26.
📅 குறுகிய காலம்The sharp recovery in operational numbers and improved return ratios could provide near-term sentiment support following a subdued FY26.
📈 நீண்ட காலம்Long-term trajectory depends on scaling value-added Isostearic Acid exports to 25-50% of sales and defending pricing against domestic specialty chemical competitors.
⚠ அபாய எச்சரிக்கைகள்
European regulatory compliance delays (REACH) for Isostearic Acid exports
Heightened competition and demand cyclicality from end-user segments like paints and coatings
👀 கவனிக்க வேண்டியவை
Track whether the strong operating margin recovery in H1 FY27 sustains in the upcoming quarters and monitor the regulatory progress on European approvals for Isostearic Acid exports.
Q2 FY27 Net Profit Jumps to ₹10.17 Cr; ₹12.01 Cr Land Purchase from Promoters Approved
Fairchem Organics reported Q2 FY27 (period ended September 30, 2026) revenue from operations of ₹166.92 Cr, up 49.7% YoY from ₹111.52 Cr in Q2 FY26, though down 5.2% QoQ from ₹176.15 Cr. Net profit rose sharply YoY to ₹10.17 Cr compared to ₹0.77 Cr in Q2 FY26 and ₹10.01 Cr in Q1 FY27, taking H1 FY27 PAT to ₹20.18 Cr. In addition, the Board approved a related party transaction to purchase two pieces of adjoining land (6,182 sq. meters) from Promoter/CMD Nahoosh Jariwala and relatives for ₹12.01 Cr (~4.6% of net worth).
உச்சம் நம்பிக்கை
என்ன மாறியதுFairchem reported a sharp YoY earnings turnaround in Q2 FY27 and approved a ₹12.01 Cr related-party land acquisition adjacent to its Sanand plant.
ஏன் இது முக்கியம்The company's H1 FY27 net profit of ₹20.18 Cr already exceeds full-year FY26 earnings, indicating an operational recovery, while the land acquisition expands site footprint.
Revenue from operations (Q2 FY27): ₹16,692.38 லட்சம்Net Profit (Q2 FY27): ₹1,016.76 லட்சம்Land Acquisition Value: ₹12.01 CroresLand Deal vs Net Worth: ~4.6%Land Area: 6,182 Sq. Mtrs.
📅 குறுகிய காலம்Strong YoY recovery in quarterly earnings should support positive sentiment, though related party land purchases often draw governance scrutiny.
📈 நீண்ட காலம்Sustaining quarterly run-rates of >₹10 Cr PAT would fundamentally re-base the business earnings compared to FY25-FY26 downcycles.
⚠ அபாய எச்சரிக்கைகள்
Related-party transaction of ₹12.01 Cr with Promoter/CMD and relatives for land purchase
Raw material price volatility and end-market demand cyclicality in specialty chemicals
👀 கவனிக்க வேண்டியவை
Track whether sustained profitability continues into H2 FY27 and watch for disclosures regarding the end-use of the newly acquired adjoining land.
Q1 FY27 Revenue up 34.4% YoY to Rs 176 Cr; EBITDA Margins Recover to 10.14%
Fairchem Organics reported a strong start to FY27 with Q1 revenue of Rs 176 Cr, a 34.4% YoY increase. Profitability showed a sharp recovery with a PAT of Rs 10 Cr for the quarter, already exceeding the total TTM PAT of Rs 6 Cr. EBITDA margins improved to 10.14%, driven by higher price realizations and operational efficiencies, including a 30% reduction in power consumption. Management has provided a volume growth guidance of 15-20% for the full year FY27.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has moved from a period of subdued margins and flat growth to a high-growth phase with double-digit EBITDA margins in Q1 FY27.
ஏன் இது முக்கியம்The sharp recovery in PAT (Rs 10 Cr in one quarter vs Rs 6 Cr in the previous 12 months) suggests that cost-optimization and pricing power are returning, potentially re-rating the stock from its current high P/E levels.
📅 குறுகிய காலம்The stock is likely to react positively to the significant earnings beat and margin expansion compared to the previous fiscal year.
📈 நீண்ட காலம்Structural growth depends on the successful scaling of the Isostearic acid business and maintaining the 10%+ margin profile amidst global chemical price volatility.
⚠ அபாய எச்சரிக்கைகள்
Regulatory delays in European market registrations
Raw material price volatility
Geopolitical tensions in the Middle East affecting supply chains
👀 கவனிக்க வேண்டியவை
Watch for the successful completion of European regulatory registrations (REACH) which is critical for the planned ramp-up of high-margin Isostearic acid exports.
755% YoY PAT Growth in Q1 FY27; Revenue up 34% to ₹176.49 Cr
Fairchem Organics reported a robust Q1 FY27 with total income rising 34.5% YoY to ₹176.49 Cr. Net profit surged to ₹10.01 Cr from ₹1.17 Cr in the same quarter last year, representing a massive 755% increase. This quarterly revenue alone represents approximately 38.4% of the company's total TTM revenue of ₹460 Cr, indicating a significant acceleration in business activity. Basic EPS for the quarter improved to ₹7.95, which already exceeds the full-year FY26 EPS of ₹4.28.
உச்சம் நம்பிக்கை
என்ன மாறியதுFairchem Organics has delivered a sharp turnaround in profitability and revenue growth in Q1 FY27 after a period of subdued performance in FY25 and FY26.
ஏன் இது முக்கியம்The significant margin expansion (PAT margin rising to 5.7% from 0.9% YoY) suggests the company may have overcome competitive pressures or successfully ramped up high-margin specialty chemical exports.
Q1 FY27 Revenue: ₹176.49 கோடிQ1 FY27 PAT: ₹10.01 கோடிYoY PAT Growth: 755%Q1 வருவாய் vs TTM வருவாய்: 38.4%Basic EPS (Q1): ₹7.95
📅 குறுகிய காலம்The stock is likely to react positively to this substantial earnings beat, as the quarterly profit has already surpassed the previous full year's performance.
📈 நீண்ட காலம்If this performance marks the successful entry into European markets for Isostearic Acid, it could lead to a structural re-rating of the business given the niche leadership position.
⚠ அபாய எச்சரிக்கைகள்
Sustainability of high margins
Raw material price volatility
Regulatory compliance risks in export markets
👀 கவனிக்க வேண்டியவை
Investors should monitor the sustainability of these improved margins and check if the growth is driven by the previously delayed Isostearic Acid exports to Europe. Watch for the full quarterly report to assess if raw material costs or product mix shifts contributed to the 755% profit surge.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Fairchem Organics Q1 FY27: PAT at Rs 10 Cr exceeds TTM total; Export target 50%
Fairchem Organics reported a significant turnaround in Q1 FY27, with a PAT of Rs 10.0 Cr, which already exceeds the total TTM PAT of Rs 6 Cr. Revenue for the quarter reached Rs 176.1 Cr, representing approximately 38% of the TTM revenue, indicating a sharp recovery in operational performance. The company is aggressively targeting the export market, aiming to increase the export mix to 50% of total sales, supported by favorable US tariffs and proposed FTAs with the EU/UK. Despite a difficult FY26 where ROCE fell to 3.88%, the Q1 EBITDA of Rs 17.9 Cr suggests a potential margin expansion phase.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has demonstrated a sharp recovery in profitability in Q1 FY27 after a period of subdued earnings and high competition in FY26.
ஏன் இது முக்கியம்The jump in quarterly PAT suggests that the company's 'waste-to-wealth' model is regaining pricing power or volume efficiency, which is critical for a business with a high P/E ratio of 190.2.
📅 குறுகிய காலம்The stock may react positively to the earnings turnaround, as Q1 profits alone have surpassed the previous four quarters combined.
📈 நீண்ட காலம்Long-term value depends on successfully scaling Isostearic Acid exports to Europe and Japan and maintaining the low-cost raw material advantage.
⚠ அபாய எச்சரிக்கைகள்
Regulatory delays in European REACH compliance
High client concentration in the paint and coatings industry
Volatility in vegetable oil refinery by-product availability
👀 கவனிக்க வேண்டியவை
Investors should monitor the sustainability of these improved margins in upcoming quarters and track the progress of European REACH regulatory compliance for Isostearic Acid exports.
Fairchem Organics reported a sharp recovery in Q1 FY27, with revenue from operations reaching ₹176.15 cr, a 34.4% increase compared to ₹131.06 cr in Q1 FY26. Net profit surged to ₹10.01 cr from ₹1.17 cr in the year-ago period, representing a 755% YoY growth. The quarterly EPS of ₹7.95 has already exceeded the entire TTM EPS of ₹4.24, indicating a significant operational turnaround. This performance follows a period of subdued demand and regulatory delays in the European market.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has delivered a significant beat on both revenue and profitability compared to the previous four quarters, reversing a trend of declining margins.
ஏன் இது முக்கியம்The sharp jump in profitability suggests that the company may have successfully navigated competitive pressures and regulatory hurdles that previously suppressed its OPM to 4.7%.
Revenue (Q1 FY27): ₹176.15 கோடிPAT (Q1 FY27): ₹10.01 கோடிQ1 வருவாய் vs TTM வருவாய்: ~38.3%YoY PAT Growth: 755.5%EPS (Q1 FY27): ₹7.95
📅 குறுகிய காலம்The stock is likely to react positively in the short term as the earnings significantly exceed recent quarterly run-rates and historical TTM performance.
📈 நீண்ட காலம்If the company maintains this quarterly run-rate, it could lead to a significant re-rating of the stock, which currently trades at a high P/E due to depressed historical earnings.
⚠ அபாய எச்சரிக்கைகள்
Raw material cost sensitivity (consumed ~68% of revenue)
High dependence on the paint and coatings industry
Increased finance costs
👀 கவனிக்க வேண்டியவை
Investors should monitor management commentary regarding the sustainability of these margins and the status of Isostearic Acid exports to Europe. The key factor to watch is whether this volume growth is a one-off recovery or a structural ramp-up following REACH compliance.
Rs 173.99 Cr: CARE Reaffirms 'CARE A; Stable' Rating; Long-term Bank Facilities Enhanced
CARE Ratings has reaffirmed Fairchem Organics' long-term credit rating at 'CARE A; Stable' and short-term rating at 'CARE A1'. A significant detail is the enhancement of rated long-term bank facilities from Rs 123.99 crore to Rs 173.99 crore. This Rs 50 crore increase in rated limits represents approximately 11% of TTM revenue and 19% of the current net worth, providing additional financial headroom. The reaffirmation comes despite a challenging period where OPM has moderated to 4.7% and TTM PAT stands at Rs 6 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுCARE Ratings reaffirmed the company's credit ratings while increasing the total amount of rated long-term bank facilities by Rs 50 crore.
ஏன் இது முக்கியம்The reaffirmation validates the company's creditworthiness despite recent profitability pressures, while the enhanced limits provide the necessary liquidity to support future growth or working capital needs.
Enhanced Long-term Facilities: Rs 173.99 கோடிPrevious Long-term Facilities: Rs 123.99 கோடிTotal Rated Facilities vs TTM Revenue: ~39.4%Total Rated Facilities vs Net Worth: ~68.9%
📅 குறுகிய காலம்The reaffirmation is likely to be viewed neutrally by the market as it maintains the status quo on credit quality.
📈 நீண்ட காலம்The increased credit limits support the company's long-term strategy to expand its specialty chemical portfolio and target the European export market.
⚠ அபாய எச்சரிக்கைகள்
Moderating profitability (OPM 4.7%)
Regulatory delays in European market entry
High P/E ratio of 159.1 relative to current earnings
👀 கவனிக்க வேண்டியவை
Monitor the utilization of the additional Rs 50 crore credit limit to see if it funds the strategic ramp-up of Isostearic Acid exports once European regulatory hurdles are cleared.
Fairchem Organics Q4 FY26: PAT at ₹3.7 Cr; Targets 80% Capacity Utilization in FY27
Fairchem Organics reported a 14.5% YoY decline in annual revenue to ₹460 crores for FY26, with a full-year net profit of ₹6.2 crores. Despite the annual dip, Q4 FY26 showed signs of recovery with EBITDA margins improving to 6.9% due to better domestic price realizations and reduced Chinese dumping. The company successfully completed a buyback of 4.25 lakh shares, increasing promoter holding to 63.2%. Management is optimistic about FY27, targeting 80% capacity utilization and an increase in export share from 9% to 20%.
முக்கிய அம்சங்கள்
FY26 revenue declined 14.5% to ₹460 crores, with Q4 revenue at ₹117 crores.EBITDA margins improved to 6.9% in Q4 FY26, up from the full-year average of 4.7%.Management targets 80% capacity utilization in FY27 and 95% within two years.Export revenue share is projected to grow from the current 9% to approximately 20%.Promoter holding increased from 61.2% to 63.2% following a buyback of 4.25 lakh shares.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to scale capacity utilization and exports as guided, which could lead to significant operating leverage. The reduction in Chinese dumping and recovery in the paint industry are key positive triggers to watch.
Fairchem Organics Q4 FY26 PAT Surges 521% YoY to ₹37 Mn Despite Marginal Revenue Dip
Fairchem Organics reported a sharp recovery in profitability for Q4 FY26, with PAT jumping 521.8% YoY to ₹37 million, driven by EBITDA margins expanding to 6.87%. While quarterly revenue saw a slight decline of 3.2% YoY to ₹1,169 million due to weak demand from the paint industry, domestic realizations improved as imports reduced. The company is pivoting towards high-value products like Isostearic Acid and expanding its export footprint in the US and EU. For the full year FY26, the company recorded a revenue of ₹4,596 million and a PAT of ₹62 million.
முக்கிய அம்சங்கள்
Q4 FY26 PAT increased by 521.8% YoY to ₹37 million compared to ₹6 million in Q4 FY25.EBITDA margins expanded by 321 bps to 6.87% in Q4 FY26 from 3.66% in the year-ago period.Revenue for the quarter stood at ₹1,169 million, reflecting a minor decline of 3.2% YoY.Successfully completed a share buy-back worth ₹340 million in January 2026.Strategic focus on forward integration into Isostearic Acid to target high-growth global markets.
👀 கவனிக்க வேண்டியவை
Investors should focus on the significant margin recovery and the company's ability to maintain profitability despite revenue headwinds in the paint sector. The focus on value-added exports and the recent buy-back indicate management's confidence in the long-term business model.
Fairchem Organics reported a decline in annual revenue from operations to ₹45,964.82 Lakhs for FY26, down from ₹53,789.84 Lakhs in FY25. For the quarter ended March 31, 2026, revenue stood at ₹11,692.84 Lakhs, showing a slight recovery from the preceding quarter but remaining lower than the year-ago period. The Board has recommended a dividend of ₹1.00 per equity share (10% of face value) for the financial year. Additionally, the company has proposed the re-appointment of Sudhin Choksey as an Independent Director for a second five-year term starting in 2027.
முக்கிய அம்சங்கள்
Annual Revenue from Operations decreased by 14.5% year-on-year to ₹45,964.82 Lakhs in FY26.Quarterly revenue for Q4 FY26 was ₹11,692.84 Lakhs compared to ₹12,078.07 Lakhs in Q4 FY25.Board recommended a dividend of ₹1.00 per equity share (10% of face value) with a record date of July 20, 2026.Sudhin Choksey re-appointed as Independent Director for a second term from February 2027 to February 2032.Cost of materials consumed for FY26 stood at ₹37,419.19 Lakhs, down from ₹41,974.92 Lakhs in the previous year.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company has seen a significant contraction in annual revenue. Monitor the upcoming AGM on July 27, 2026, for management commentary on growth recovery and margin sustainability.
Fairchem Organics Q3 FY26 Revenue Drops 12% to ₹100 Cr; EBITDA Margins Squeeze to 4.2%
Fairchem Organics reported a weak Q3 FY26 with revenue declining 12% YoY to ₹100 crores and EBITDA falling to ₹4 crores due to lower demand from the paint sector and Chinese dumping. Profitability was severely impacted by a duty inversion where raw materials face 16.5% duty while finished products face only 7.5%. Management expects a gradual recovery starting H2 FY27, supported by new trade agreements with the US and EU and the launch of an animal feed plant. The company is also working on cost-saving measures and domestic catalyst replacement to improve margins.
முக்கிய அம்சங்கள்
Q3 Revenue stood at ₹100 crores, a 12% YoY decline, while 9M FY26 revenue fell 18% to ₹343 crores.EBITDA margins compressed to 4.2% in Q3 and 3.97% for 9M FY26, impacted by elevated raw material costs.Adjusted PAT for the quarter was ₹60 lakhs (0.6% margin) after an ₹88 lakh exceptional item for labor code implementation.Management highlighted a duty disadvantage with raw material duties at 16.5% versus 7.5% for imported dimer acid.Animal feed plant is ready and awaiting GMP certification, with a new value-added product slated for Q3 FY27.
👀 கவனிக்க வேண்டியவை
Investors should remain cautious as the company faces significant margin pressure from Chinese imports and high raw material duties. Monitor the recovery in export volumes to the US and the commissioning of the animal feed plant in the coming quarters for signs of a turnaround.
Fairchem Organics Q3 FY26 PAT Plummets 83% YoY to INR 6 Mn Amid Margin Pressure
Fairchem Organics reported a weak performance for Q3 FY26, with revenue declining 12% YoY to INR 1,001 Mn and PAT (excluding exceptional items) dropping 83% to INR 6 Mn. EBITDA margins contracted significantly to 4.20% from 6.87% a year ago, driven by elevated raw material costs and aggressive pricing from Chinese competitors. The company faced headwinds in the domestic paint segment due to a new market entrant and a temporary halt in US exports. Management expects a recovery in high-margin exports following recent tariff adjustments in the US and potential FTAs with the UK and EU.
முக்கிய அம்சங்கள்
Q3 FY26 Revenue fell 11.9% YoY to INR 1,001 Mn, while 9M FY26 revenue dropped 17.8% to INR 3,427 Mn.EBITDA for Q3 FY26 declined by 46.2% YoY to INR 42 Mn, with margins shrinking by 267 bps to 4.20%.PAT (excluding exceptional items) saw a sharp decline of 82.9% YoY, reaching only INR 6 Mn for the quarter.Raw material costs remained high due to a 16.5% custom duty compared to the original 5.5%, impacting Dimer Acid margins.Successfully concluded a buyback of INR 340 Mn in January 2026, increasing promoter holding to 63.25%.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company faces intense margin pressure from high input costs and Chinese competition. Monitor the ramp-up of exports to the US and Europe as the primary catalyst for a potential recovery in profitability.
Fairchem Organics Reports Q3 FY26 Net Loss of ₹9.71 Lakhs; Revenue Down 11.8% YoY
Fairchem Organics reported a weak performance for the quarter ended December 31, 2025, with revenue from operations declining 11.8% YoY to ₹10,013.40 Lakhs. The company swung to a net loss of ₹9.71 Lakhs from a profit of ₹351.78 Lakhs in the previous year's corresponding quarter. Performance was impacted by an exceptional charge of ₹88.27 Lakhs related to new labor code regulations and overall margin compression. For the nine-month period, net profit plummeted by over 91% YoY to ₹184.87 Lakhs.
முக்கிய அம்சங்கள்
Revenue from operations decreased to ₹10,013.40 Lakhs in Q3 FY26 from ₹11,357.08 Lakhs in Q3 FY25.Reported a net loss of ₹9.71 Lakhs for the quarter compared to a profit of ₹351.78 Lakhs YoY.Nine-month PAT (9M FY26) stood at ₹184.87 Lakhs, a 91.3% decline from ₹2,138.06 Lakhs in 9M FY25.Recognized an exceptional expense of ₹88.27 Lakhs due to the implementation of the Code on Wages, 2019.Completed a buyback of 4,25,000 equity shares at ₹800 per share for a total of ₹34 Crores in January 2026.
👀 கவனிக்க வேண்டியவை
The significant drop in profitability and revenue suggests severe margin pressure in the specialty chemicals segment. Investors should remain cautious and monitor the company's ability to pass on costs and improve operational efficiency in upcoming quarters.
Fairchem Organics Completes Extinguishment of 4.25 Lakh Equity Shares Post-Buyback
Fairchem Organics has successfully completed the extinguishment of 4,25,000 equity shares following its recent buyback program. This action has reduced the company's total paid-up share capital from 1,30,20,902 shares to 1,25,95,902 shares, representing a reduction of approximately 3.26%. The extinguishment was finalized on January 27, 2026, in compliance with SEBI Buy-Back Regulations. Such a reduction in the share base typically leads to an improvement in Earnings Per Share (EPS) and Return on Equity (ROE) for existing shareholders.
முக்கிய அம்சங்கள்
Extinguished 4,25,000 equity shares of face value Rs. 10 each on January 27, 2026Total paid-up share capital reduced from INR 13.02 crore to INR 12.60 croreTotal outstanding equity shares decreased from 1,30,20,902 to 1,25,95,902The buyback tendering period was conducted between January 8 and January 14, 2026The extinguishment was confirmed by CDSL and verified by secretarial auditors
👀 கவனிக்க வேண்டியவை
The reduction in equity base is a positive development that enhances shareholder value through improved financial ratios. Investors should hold their positions as the lower share count will marginally boost future EPS.
Fairchem Organics Completes Buyback of 76,045 Equity Shares at ₹1,315 Per Share
Fairchem Organics Limited has successfully concluded its share buyback program through the tender offer route. The company repurchased 76,045 equity shares at a price of ₹1,315 per share, involving a total capital outlay of ₹10 crore. This buyback has resulted in a reduction of the total paid-up equity capital, which may lead to a marginal improvement in Earnings Per Share (EPS) for remaining shareholders.
முக்கிய அம்சங்கள்
Repurchased 76,045 equity shares at a premium price of ₹1,315 per share.Total buyback size amounted to ₹10 crore, excluding transaction costs and taxes.The buyback was conducted via the Tender Offer route as per SEBI regulations.Post-buyback, the total number of equity shares has been reduced, potentially enhancing return ratios.
👀 கவனிக்க வேண்டியவை
As the buyback is now complete and shares have been extinguished, investors should focus on the company's operational performance and the resulting impact on EPS in the next quarterly report.
Fairchem Organics Announces Buyback of 4.25 Lakh Shares at ₹800 Per Share via Tender Offer
Fairchem Organics Limited has issued a Letter of Offer for the buyback of up to 4,25,000 equity shares at a price of ₹800 per share, totaling ₹3,400 lakhs. The buyback represents 3.26% of the total equity and 16% of the company's paid-up capital and free reserves as of March 2025. The process will be conducted via the tender offer route, with the acceptance window open from January 8 to January 14, 2026. The record date for determining eligibility was January 5, 2026.
முக்கிய அம்சங்கள்
Buyback of 4,25,000 shares at a fixed price of ₹800 per share via tender routeTotal buyback size of ₹3,400 lakhs represents 16% of the company's net worthSmall shareholder entitlement ratio is approximately 29 shares for every 488 shares heldGeneral category entitlement ratio is approximately 55 shares for every 606 shares heldTendering period scheduled from January 8, 2026, to January 14, 2026
👀 கவனிக்க வேண்டியவை
Eligible shareholders should evaluate the premium of the ₹800 buyback price over the current market price and consider tendering their shares before the January 14 deadline.
Fairchem Organics Shareholders Approve ₹34 Crore Buyback at ₹800 Per Share
Fairchem Organics Limited has received shareholder approval via postal ballot for a buyback of up to 4,25,000 equity shares. The buyback is priced at ₹800 per share, representing a premium of approximately 14.77% over the closing price on the date of the board's initial approval. The total buyback size is capped at ₹3,400 lakhs, which accounts for 16% of the company's total paid-up equity capital and free reserves. The process will be conducted through the tender offer route, providing an opportunity for shareholders to exit at a premium.
முக்கிய அம்சங்கள்
Buyback of up to 4,25,000 fully paid-up equity shares at ₹800 per shareTotal buyback size capped at ₹3,400 lakhs, representing 16% of aggregate paid-up capital and free reservesBuyback to be executed through the 'Tender Offer' route on a proportionate basis15% reservation of the buyback size (63,750 shares) for small shareholders as per SEBI regulationsThe buyback price represents a premium of ~14.16% and ~14.77% over BSE and NSE closing prices as of Nov 20, 2025
👀 கவனிக்க வேண்டியவை
Investors should watch for the announcement of the Record Date to determine eligibility for participation in the tender offer. Small shareholders may find this particularly attractive due to the 15% reservation and the premium over current market prices.
Fairchem Organics Shareholders Approve Equity Share Buyback with 99.99% Majority
Fairchem Organics Limited has received overwhelming shareholder approval for its proposed equity share buyback via the tender offer route. The postal ballot results showed that 99.99% of the votes cast, totaling 8,552,615 shares, were in favor of the special resolution. The voting process concluded on December 26, 2025, following a month-long e-voting period. This approval allows the company to proceed with the buyback, which is typically viewed as a positive signal regarding management's confidence in the company's valuation.
முக்கிய அம்சங்கள்
Special resolution for buyback of equity shares passed with 99.99% majority support.A total of 8,552,615 votes were cast in favor, while only 1,034 votes (0.01%) were against.The buyback will be conducted through the tender offer route as per SEBI regulations.The voting period for the postal ballot ran from November 26 to December 26, 2025.
👀 கவனிக்க வேண்டியவை
Investors should monitor upcoming disclosures for the specific buyback price and record date to evaluate the potential premium. This move suggests a healthy cash position and a commitment to returning value to shareholders.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
